Protection of Human Subjects and Institutional Review Boards
Revision of a currently approved collection
No
Regular
Approved without change
12/26/2023
11/27/2023
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
12/31/2026
36 Months From Approved
03/31/2026
347,930
0
346,828
1,627,905
0
1,626,803
0
0
0
The information collection supports implementation of statutory and regulatory requirements pertaining to the rights and welfare of human subjects involved in FDA-regulated research, and applicable to Institutional Review Boards that oversee such research.
US Code:
21 USC 301 et. seq.
Name of Law: Federal Food, Drug, and Cosmetic Act
US Code:
42 USC 241; 289
Name of Law: Public Health and Welfare; Institutional Review Boards
PL: Pub.L. 114 - 255 3024 Name of Law: 21st Century Cures Act
We estimate the rulemaking will result in an annual burden increase of 1,102 responses and 1,102 hours from recordkeeping and disclosure activity relating to the revised regulations in 21 CFR parts 50 and 56.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.